Danes target opportunities in Britain:
This article was originally published in Clinica
Executive Summary
The Danish Embassy in London is promoting commercial opportunities in British hospitals to medical device manufacturers in Denmark. It is confident that the modernisation of the British healthcare sector offers significant opportunities with greater resources and more streamlined purchasing processes. To help its compatriots, the Embassy is organising a workshop in London on November 11, entitled: Selling to the Public Healthcare Sector in the UK - Recent Development in Purchasing, Practices and Policy.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.